<DOC>
	<DOCNO>NCT00222014</DOCNO>
	<brief_summary>The main end point study ass survival cirrhotic patient refractory ascites treat TIPS ( use PTFE cover stent ) vs patient treated paracentesis + albumin infusion .</brief_summary>
	<brief_title>TIPS With Coated Stents Refractory Ascites Patients With Cirrhosis</brief_title>
	<detailed_description>Diagnostic evaluation randomisation include assessment clinical hepatic encephalopathy , usual blood test , Doppler-ultrasonography abdomen . Inclusion exclusion criterion check inclusion visit . Informations concern trial also give . After investigator receives write informed consent , randomisation perform online . Randomisation centralize , equilibrate center , stratify accord whether cirrhosis alcoholic adjust every ten patient . I Treatments 1 . TIPS : TIPS perform sedation general anesthesia tracheal intubation accord usual policy participate center . Pre-tips portosystemic pressure gradient diameter shunt must notify . However , homogeneity reason follow adhere : A 10 mm Viator stent use , dilate 8 10 mm accord hemodynamic response . The aim reduce portal pressure gradient ( PPG ) 12 mmHg . Ideal PPG 7-8 mmHg . 2 . Paracentesis + albumin infusion : After paracentesis &gt; 3 liter , 8 g Albumin per liter extract ascites must infuse . If possible , analysis ascitic fluid perform paracentesis biochemical , cytological bacterial analysis . II Follow 1 . In patient : Low salt diet ( 2 - 4 g/j ) . Follow patient usual . Patients clinical examination 1 month every 3 month 1 year . At visit , clinical biochemical variable need calculate Child-Pugh score record . Doppler ultrasonography perform beginning , 6 12 month . Patients follow 1 year liver transplantation death . 1 . Nutritional status evaluation : - Weight : M0 , M3 , M6 , M9 , M12 - Anthropometrics measurement : M0 , M3 , M6 , M12 : include : triceps skinfold thickness , biceps skinfold thickness , brachial circumference . - Biochemical parameter : M0 , M3 , M6 , M12 : include : albumin , pre-albumin , orosomuco√Øde , C-reactive protein , haptoglobin , natriuresis , 24 hour urinary excretion creatinine . Four blood sample collect conserved posteriori analysis require ( transferrin , retinol binding protein , leptin , hormonal dosage ) . These analysis centralize Toulouse ( Toulouse center charge shipment blood sample ) . - Physical parameter : dual energy x-ray absorptiometry M0 , M12 - Grip test M0 , M6 , M12 [ 16 , 17 ] . 2 . Quality Life : SF-36 ( Short Form 36 ( SF-36 ) Health Survey Questionnaire ) inclusion every three month [ 18 , 19 ] . 2 . Paracentesis + albumin infusion group : Patients include group treat paracentesis whenever require . Eight gram albumin per liter ascites extract infused 3 liter ascitic fluid remove . 3 . TIPS group : When shunt dysfunction suspect relapse ascites incomplete response 2 month procedure , angiography PPG measurement perform . If shunt dysfunction confirm , angioplasty PTFE re-stenting aim reduce PPG 12 mmHg . III Definition treatment failure : After TIPS : relapse ascites require least 2 paracenteses persistence 2 month consider treatment failure . A hemodynamic angiographic control perform . Patients treated refection shunt . If severe encephalopathy occur persist despite treatment , diameter shunt decrease TIPS occlude . Total occlusion shunt relapse ascites reduction diameter also consider treatment failure . In group treat paracentesis + albumin infusion , patient 6 paracenteses within 3 month consider alternative treatment ( TIPS , transplantation ) . Technical impossibility refusal patient proceed paracenteses also consider treatment failure . In case , TIPS could also propose . All patient treatment failure must follow one year inclusion</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<criteria>patient sex , cirrhosis , document previous liverbiopsy usual clinical biochemical stigma refractory recurrent ascites define chapter IV sign informed consent form patient fulfil inclusion criterion patient need 6 paracenteses within last 3 month patient expect transplanted within next 6 month usual contraindication TIPS : congestive heart failure NYHA &gt; III medical history pulmonary hypertension , portal vein thrombosis , hepatic polycystosis , intrahepatic bile duct dilatation , spontaneous clinical recurrent hepatic encephalopathy hepatocarcinoma expect tract shunt severe liver failure define : Prothrombin index &lt; 35 % total bilirubin &gt; 100 micromol/l Child Pugh Score &gt; 12 serum creatinine &gt; 250 micromol/l uncontrolled sepsis know allergy albumin pregnant breast feed woman refusal participate patient unable receive information sign write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Refractory ascites</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Paracentesesis</keyword>
</DOC>